JA Jakubowski, KJ Winters, H Naganuma, L … - Cardiovascular Drug Reviews, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 43 - Related articles - BL Direct - All 3 versions
DS Small, NA Farid, YG Li, C Steven Ernest II … - Current Medical Research and Opinion®, 2008 - informahealthcare.com Objective: Clopidogrel is an oral thienopyridine antiplatelet agent indicated
for the treatment of atherothrombotic events in patients with acute coronary
syndrome (ACS). Prasugrel, a novel oral thienopyridine, is under ... Cited by 15 - Related articles - All 7 versions
P Owen, J Garner, L Hergott, RL Page - Pharmacotherapy, 2008 - PPI The antiplatelet drug clopidogrel is an oral thienopyridine derivative that has
been extensively used for the treatment and secondary prevention of a variety of
cardiovascular diseases. Although clopidogrel is well tolerated by most ... Cited by 6 - Related articles - BL Direct - All 2 versions
F Krötz, HY Sohn, V Klauss - Vascular Health and Risk Management, 2008 - pubmedcentral.nih.gov A common pathophysiological course in vascular diseases is an overwhelming
activation and aggregation of blood platelets, which results in
atherothrombosis. By causing the last decisive step of cerebral, coronary, ... Cited by 3 - Related articles - All 7 versions
P Hjemdahl - British Medical Journal, 2008 - heart.bmj.com Antiplatelet drug treatment is a cornerstone in cardiovascular prevention.
Low-dose aspirin (ASA) inhibits platelet-dependent, cyclo-oxygenase-1
(COX-1)-mediated thromboxane formation from arachidonic acid (AA), and is ... Cited by 3 - Related articles - BL Direct - All 4 versions
AB MSc, JACD PhD, LEL BScPhm, ND PhD, MD … - pharmacoepidemiology and drug safety, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 1 - Related articles - All 4 versions
Z Motovska, P Widimsky - Vascular Health and Risk Management, 2009 - pubmedcentral.nih.gov Dual oral antiplatelet therapy, aspirin plus thienopyridine, has permitted a
rapid increase in the use of coronary intervention procedures. Clopidogrel is
the thienopyridine of choice for dual antiplatelet therapy in patients ... Related articles - All 5 versions
